Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.

被引：0
|
作者：
Hyldstrup, L
Jorgensen, JT
Gaich, G
机构：
[1] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, Copenhagen, Denmark
[2] Pronosco AS, Vedbaek, Denmark
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
BONE | 2001年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [41] Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing
    Nakazawa, T
    Nakajima, A
    Shiomi, K
    Moriya, H
    Einhorn, TA
    Yamazaki, M
    BONE, 2005, 37 (05) : 711 - 719
  • [42] Recombinant human parathyroid hormone (1-34) therapy reduces the incidence of moderate/severe vertebral fractures in men with low bone density.
    Orwoll, E
    Scheele, WH
    Clancy, AD
    Adami, S
    Syversen, U
    Diez-Perez, A
    Myers, SL
    Mitlak, BH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S162 - S162
  • [43] Effects of long-term immobilisation on cortical bone mass after traumatic amputation of the phalanges estimated by digital X-ray radiogrammetry
    M.-L. Schäfer
    A. Pfeil
    D. M. Renz
    G. Lehmann
    M. Schmidt
    A. Hansch
    G. Hein
    G. Wolf
    W. A. Kaiser
    J. Böttcher
    Osteoporosis International, 2008, 19 : 1291 - 1299
  • [44] Continuous and intermittent treatment of zebrafish with recombinant human parathyroid hormone (1-34) have opposite effects on the growing fish skeleton.
    Fleming, A
    Sato, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S334 - S335
  • [45] EFFECTS IN GREYHOUNDS ON BONE TURNOVER AND BONE-DENSITY AFTER CONTINUOUS SUBCUTANEOUS INFUSION OF HUMAN PARATHYROID-HORMONE (1-34) FRAGMENT
    PODBESEK, RD
    ELSASSER, U
    ZANELLI, GD
    PARSONS, JA
    REEVE, J
    CLINICAL SCIENCE, 1980, 58 (02) : P32 - P32
  • [46] Digital X-ray radiogrammetry (DXR) versus quantitative ultrasound (QUS): Assessment of disease activity dependent cortical bone loss in rheumatoid arthritis
    Pfeil, A.
    Boettcher, J.
    Mentzel, H. J.
    Schaefer, M. L.
    Schmidt, M.
    Oelzner, P.
    Lehmann, G.
    Malich, A.
    Petrovitch, A.
    Kaiser, W. A.
    Hein, G.
    Wolf, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 592 - 592
  • [47] Effects of withdrawal and re-administration of human parathyroid hormone (1-34) on whole body bone density in ovariectomized rat.
    Kishi, T
    Hagino, H
    Yamamoto, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : T528 - T528
  • [48] Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora
    Komatsubara, S
    Mori, S
    Mashiba, T
    Nonaka, K
    Seki, A
    Akiyama, T
    Miyamoto, K
    Cao, YP
    Manabe, T
    Norimatsu, H
    BONE, 2005, 36 (04) : 678 - 687
  • [49] Brief therapy with recombinant human parathyroid hormone (1-34) increases lumbar spine bone mineral density in men with idiopathic or hypogonadal osteopenia.
    Orwoll, E
    Scheele, WH
    Paul, S
    Adami, S
    Syversen, U
    Diez-Perez, A
    Gaich, GA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S221 - S221
  • [50] Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice (vol 43, pg 238, 2008)
    Sugiyama, Toshihiro
    Saxon, Leanne K.
    Zaman, Gul
    Moustafa, Alaa
    Sunters, Andrew
    Price, Joanna S.
    Lanyon, Lance E.
    BONE, 2009, 45 (06) : 1192 - 1195
12345